TRAVERE THERAPEUTICS, INC.
- SAN DIEGO, CA 92130-3331
- travere.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM expiring
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $1.1M
- Awards on record
- 32
- Contract vehicles
- 0
- Verified credentials
- 0
SAM.gov registration expires in 27 days
TRAVERE THERAPEUTICS, INC.’s registration expires on Dec 10, 2026. Renewal can take weeks; confirm it stays active through proposal submission and award.
View on SAM.gov (opens in a new tab)Learn more about SAM registration and the UEI
About TRAVERE THERAPEUTICS, INC.
- Headquarters
- SAN DIEGO, CA 92130-3331
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIJUBZMHK84S36
- CAGE77HN5
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $1.1M
- Awards on record
- 32
- Top funding agencies
- Department of Veterans Affairs
25 most recent of 32 awards
36C26226N0373
Recompete < 6 mo: Potential end Feb 9, 2027 (2 months away)EMERGENCY THIOLA 100 MG TABLETS
Department of Veterans Affairs
- Obligated
- $131.5K
- Period of performance
- Feb 10, 2026 – Feb 9, 2027
36C24527P0072
Completed: Period of performance ended Oct 27, 2026THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $27.5K
- Period of performance
- Oct 22, 2026 – Oct 27, 2026
36C24526N0794
Completed: Period of performance ended Aug 10, 2026PATIENT MEDICATION ORDER OF FILSPARI 400MG - WASHINGTON DC VA MEDICAL CENTER PHARMACY ORDER.
Department of Veterans Affairs
- Obligated
- $15.9K
- Period of performance
- Aug 5, 2026 – Aug 10, 2026
36C24526N0779
Completed: Period of performance ended Aug 4, 2026THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $33.4K
- Period of performance
- Jul 30, 2026 – Aug 4, 2026
36C24526N0725
Completed: Period of performance ended Jul 15, 2026FILSPARI 400 MG
Department of Veterans Affairs
- Obligated
- $15.9K
- Period of performance
- Jul 10, 2026 – Jul 15, 2026
36C24526N0675
Completed: Period of performance ended Jun 26, 2026FILSPARI 400 MG
Department of Veterans Affairs
- Obligated
- $15.9K
- Period of performance
- Jun 24, 2026 – Jun 26, 2026
36C24526N0571
Completed: Period of performance ended May 14, 2026PATIENT MEDICATION ORDER OF THIOLA 100MG FOR THE CLARKSBURG VA MEDICAL CENTER PHARMACY.
Department of Veterans Affairs
- Obligated
- $33.4K
- Period of performance
- May 7, 2026 – May 14, 2026
36C24526N0554
Completed: Period of performance ended May 1, 2026PATIENT MEDICATION THIOLA 100MG - SHIPPING TO THE CLARKSBURG VA MEDICAL CENTER'S PHARMACY.
Department of Veterans Affairs
- Obligated
- $17.7K
- Period of performance
- Apr 29, 2026 – May 1, 2026
36C24526N0284
Completed: Period of performance ended Feb 4, 2026THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $31.4K
- Period of performance
- Jan 29, 2026 – Feb 4, 2026
36C24526N0130
Completed: Period of performance ended Nov 7, 2025THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $29K
- Period of performance
- Nov 5, 2025 – Nov 7, 2025
36C25025P0025
Completed: Period of performance ended Sep 30, 2025PHARMACEUTICAL DRUG
Department of Veterans Affairs
- Obligated
- $212.6K
- Period of performance
- Oct 1, 2024 – Sep 30, 2025
36C24525N0858
Completed: Period of performance ended Aug 7, 2025THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $29K
- Period of performance
- Aug 1, 2025 – Aug 7, 2025
36C24525N0676
Completed: Period of performance ended Jun 11, 2025FILSPARI 200 MG
Department of Veterans Affairs
- Obligated
- $10.9K
- Period of performance
- Jun 4, 2025 – Jun 11, 2025
36C24525N0643
Completed: Period of performance ended May 22, 2025THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $32.8K
- Period of performance
- May 20, 2025 – May 22, 2025
36C25024P0819
Completed: Period of performance ended Mar 31, 2025CHENODAL 250MG (CHENODIOL) PHARMACY
Department of Veterans Affairs
- Obligated
- $200.6K
- Period of performance
- Apr 1, 2024 – Mar 31, 2025
36C24525N0382
Completed: Period of performance ended Feb 14, 2025THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $32.8K
- Period of performance
- Feb 13, 2025 – Feb 14, 2025
36C26024F0649
Completed: Period of performance ended Dec 18, 2024FILSPARI
Department of Veterans Affairs
- Obligated
- $11.3K
- Period of performance
- Sep 18, 2024 – Dec 18, 2024
36C24525N0194
Completed: Period of performance ended Nov 22, 2024THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $31.5K
- Period of performance
- Nov 21, 2024 – Nov 22, 2024
36C26124N0899
Completed: Period of performance ended Sep 30, 2024FILSPARI 400MG
Department of Veterans Affairs
- Obligated
- $7.4K
- Period of performance
- Sep 16, 2024 – Sep 30, 2024
36C24524N0863
Completed: Period of performance ended Aug 30, 2024THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $18.5K
- Period of performance
- Aug 29, 2024 – Aug 30, 2024
36C24524N0853
Completed: Period of performance ended Aug 27, 2024THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $11.1K
- Period of performance
- Aug 26, 2024 – Aug 27, 2024
36C26124N0736
Completed: Period of performance ended Aug 26, 2024THIOLA TIOPRONIN
Department of Veterans Affairs
- Obligated
- $11.1K
- Period of performance
- Jun 26, 2024 – Aug 26, 2024
36C24524N0760
Completed: Period of performance ended Jul 26, 2024THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $11.1K
- Period of performance
- Jul 25, 2024 – Jul 26, 2024
36C24524N0680
Completed: Period of performance ended Jun 25, 2024THIOLA 100 MG
Department of Veterans Affairs
- Obligated
- $11.1K
- Period of performance
- Jun 21, 2024 – Jun 25, 2024
36C26124N0489
Completed: Period of performance ended Jun 11, 2024THIOPRONIN
Department of Veterans Affairs
- Obligated
- $18.5K
- Period of performance
- Mar 11, 2024 – Jun 11, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
36C26226N0373 under 36F79721D0239 EMERGENCY THIOLA 100 MG TABLETS | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $131.5K | Feb 10, 2026 – Feb 9, 2027 | Recompete < 6 mo: Potential end Feb 9, 2027 (2 months away)AI brief for award 36C26226N0373Bid team for the recompete of award 36C26226N0373 |
36C24527P0072 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $27.5K | Oct 22, 2026 – Oct 27, 2026 | Completed: Period of performance ended Oct 27, 2026 |
36C24526N0794 under 36F79721D0239 PATIENT MEDICATION ORDER OF FILSPARI 400MG - WASHINGTON DC VA MEDICAL CENTER PHARMACY ORDER. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $15.9K | Aug 5, 2026 – Aug 10, 2026 | Completed: Period of performance ended Aug 10, 2026 |
36C24526N0779 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $33.4K | Jul 30, 2026 – Aug 4, 2026 | Completed: Period of performance ended Aug 4, 2026 |
36C24526N0725 under 36F79721D0239 FILSPARI 400 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $15.9K | Jul 10, 2026 – Jul 15, 2026 | Completed: Period of performance ended Jul 15, 2026 |
36C24526N0675 under 36F79721D0239 FILSPARI 400 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $15.9K | Jun 24, 2026 – Jun 26, 2026 | Completed: Period of performance ended Jun 26, 2026 |
36C24526N0571 under 36F79721D0239 PATIENT MEDICATION ORDER OF THIOLA 100MG FOR THE CLARKSBURG VA MEDICAL CENTER PHARMACY. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $33.4K | May 7, 2026 – May 14, 2026 | Completed: Period of performance ended May 14, 2026 |
36C24526N0554 under 36F79721D0239 PATIENT MEDICATION THIOLA 100MG - SHIPPING TO THE CLARKSBURG VA MEDICAL CENTER'S PHARMACY. | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $17.7K | Apr 29, 2026 – May 1, 2026 | Completed: Period of performance ended May 1, 2026 |
36C24526N0284 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $31.4K | Jan 29, 2026 – Feb 4, 2026 | Completed: Period of performance ended Feb 4, 2026 |
36C24526N0130 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $29K | Nov 5, 2025 – Nov 7, 2025 | Completed: Period of performance ended Nov 7, 2025 |
36C25025P0025 PHARMACEUTICAL DRUG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $212.6K | Oct 1, 2024 – Sep 30, 2025 | Completed: Period of performance ended Sep 30, 2025 |
36C24525N0858 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $29K | Aug 1, 2025 – Aug 7, 2025 | Completed: Period of performance ended Aug 7, 2025 |
36C24525N0676 under 36F79721D0239 FILSPARI 200 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $10.9K | Jun 4, 2025 – Jun 11, 2025 | Completed: Period of performance ended Jun 11, 2025 |
36C24525N0643 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $32.8K | May 20, 2025 – May 22, 2025 | Completed: Period of performance ended May 22, 2025 |
36C25024P0819 CHENODAL 250MG (CHENODIOL) PHARMACY | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $200.6K | Apr 1, 2024 – Mar 31, 2025 | Completed: Period of performance ended Mar 31, 2025 |
36C24525N0382 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $32.8K | Feb 13, 2025 – Feb 14, 2025 | Completed: Period of performance ended Feb 14, 2025 |
36C26024F0649 under 36F79721D0239 FILSPARI | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.3K | Sep 18, 2024 – Dec 18, 2024 | Completed: Period of performance ended Dec 18, 2024 |
36C24525N0194 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $31.5K | Nov 21, 2024 – Nov 22, 2024 | Completed: Period of performance ended Nov 22, 2024 |
36C26124N0899 under 36F79721D0239 FILSPARI 400MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $7.4K | Sep 16, 2024 – Sep 30, 2024 | Completed: Period of performance ended Sep 30, 2024 |
36C24524N0863 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $18.5K | Aug 29, 2024 – Aug 30, 2024 | Completed: Period of performance ended Aug 30, 2024 |
36C24524N0853 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.1K | Aug 26, 2024 – Aug 27, 2024 | Completed: Period of performance ended Aug 27, 2024 |
36C26124N0736 under 36F79721D0239 THIOLA TIOPRONIN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.1K | Jun 26, 2024 – Aug 26, 2024 | Completed: Period of performance ended Aug 26, 2024 |
36C24524N0760 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.1K | Jul 25, 2024 – Jul 26, 2024 | Completed: Period of performance ended Jul 26, 2024 |
36C24524N0680 under 36F79721D0239 THIOLA 100 MG | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $11.1K | Jun 21, 2024 – Jun 25, 2024 | Completed: Period of performance ended Jun 25, 2024 |
36C26124N0489 under 36F79721D0239 THIOPRONIN | Department of Veterans Affairs | 325412 · 6505DRUGS AND BIOLOGICALS | $18.5K | Mar 11, 2024 – Jun 11, 2024 | Completed: Period of performance ended Jun 11, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
No SBIR/STTR awards on record
Source: SBIR.gov award records (opens in a new tab) · sync date not recorded
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 325412Pharmaceutical Preparation ManufacturingPrimary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
No PSC codes reported.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with TRAVERE THERAPEUTICS, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.